EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis

Enrique Alvarez iD, Robert T Naismith iD, Le H Hua iD, Elmor D Pineda iD, Hela Romdhani iD, Annie Guérin iD, Mohira Lévesque-Leroux, Gayatri Marathe, Kunio Nakamura iD, Daniel Ontaneda iD

Neurology and Therapy · 2026-08 · 15 (4) · 1881-1902

DOI: 10.1007/s40120-026-00951-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Therapy, online erschienen am 30.05.2026. Verfasst von Enrique Alvarez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: F. Hoffmann-La Roche, Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Multiple sclerosisObservational studyOcrelizumabTreatment delay

Autor:innen und Institutionen

  • Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Department of Neurology, Washington University, St. Louis, MO, USA.
  • Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Las Vegas, NV, USA.
  • Genentech, Inc., 1 DNA Way Mailstop 258A, South San Francisco, CA, USA. pineda.elmor@gene.com.
  • Analysis Group, ULC, Montréal, QC, Canada.
  • Alexion Pharmaceuticals, Inc., Mississauga, ON, Canada.

ORCID-Profile: Enrique Alvarez, Robert T Naismith, Le H Hua, Elmor D Pineda, Hela Romdhani, Annie Guérin, Kunio Nakamura, Daniel Ontaneda

Förderung

  • F. Hoffmann-La Roche
  • Genentech

Zitieren

APA

Alvarez, E., Naismith, R. T., Hua, L. H., Pineda, E. D., Romdhani, H., Guérin, A., Lévesque-Leroux, M., Marathe, G., Nakamura, K., & Ontaneda, D. (2026). Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis. Neurology and Therapy, 15(4), 1881-1902. https://doi.org/10.1007/s40120-026-00951-x

Vancouver

Alvarez E, Naismith RT, Hua LH, Pineda ED, Romdhani H, Guérin A, et al. Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis. Neurology and Therapy. 2026;15(4):1881-1902. doi:10.1007/s40120-026-00951-x

BibTeX
@article{Alvarez2026,
  author = {Alvarez, Enrique and Naismith, Robert T and Hua, Le H and Pineda, Elmor D and Romdhani, Hela and Guérin, Annie and Lévesque-Leroux, Mohira and Marathe, Gayatri and Nakamura, Kunio and Ontaneda, Daniel},
  title = {Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis},
  journal = {Neurology and Therapy},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {1881--1902},
  doi = {10.1007/s40120-026-00951-x}
}
Kostenlos starten →